ACORN BIOVENTURES, L.P. → enGene Therapeutics Inc. ENGNW

Stake: — Shares: — Class: Common Shares

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

1 13D/G filings on this issuer

0 other filings besides this one

Filer Track Record

3 filings by this filer

2 other filings in the data moat

Short Interest · settle 2026-09-30

DTC 1.00

1,699 shares short · 0.0% vs prior

Other Filings by ACORN BIOVENTURES, L.P.

Filed	Form	Issuer	Stake	Shares
2026-09-25	SCHEDULE 13G/A	Karyopharm Therapeutics Inc.	—	—	view →
2026-09-25	SCHEDULE 13G/A	Karyopharm Therapeutics Inc.	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →